Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: Association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1α

Cancer Science

Volumn 95, Issue 2, 2004, Pages 149-153

  Kuwai, Toshio ^a   Kitadai, Yasuhiko ^a   Tanaka, Shinji ^b   Hiyama, Toru ^a   Tanimoto, Keiji ^c   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PARAFFIN; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; CYTOPLASM; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 1642567955     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03196.x     Document Type: Article

References (29)

1. Kaelin WG, Maher ER. The VHL tumor-suppressor gene paradigm. Trends Genet 1998; 14: 423-6.
2. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-4.
3. Crews ST. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev 1998; 12: 607-20.
4. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-62.
5. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998; 12: 3320-4.
6. Bunn HF, Polyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 76: 839-85.
7. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-78.
8. Maxwell PH, Wiesener M, Chang GW, Clifford SC, Vaux, EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
9. Kallio PJ, Wilson WJ, Obrien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1a by the ubiquitin-proteasome pathway. J Biol Chem 1999; 274: 6519-25.
10. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG Jr. Ubiquitination of hypoxia-inducible factor requires direct binding to the B-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000; 2: 423-7.
11. Cockman ME, Masson N, Mole DR, Jaakola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH. Hypoxia inducible factor-α binding and ubiquitylayion by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000; 275: 25733-41.
12. Tanimoto K, Makino Y, Pereira T, Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J 2000; 19: 4298-309.
13. Kamura T, Sato S, Iwai K, Czyzyk-Kizeska M, Conaway RC, Conaway JW. Activation of HIF-1α ubiquitination by a reconstitited von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 2000; 97: 10430-5.
14. Salceda S, Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol Chem 1997; 272: 22642-7.
15. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-92.
16. Wenger RH, Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997; 378: 609-16.
17. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000; 60: 7075-83.
18. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010-5.
19. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K. Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 2003; 105: 176-81.
20. Japanese Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 6th ed. Tokyo: Kanehara Ltd; 1992.
21. Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI, Minna JD. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 1994; 9: 1599-604.
22. Miyakis S, Sourvinos G, Liloglou TL, Stathopoulos GP, Field JK, Spandidos DA. The von Hippel-Lindau tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 2000; 88: 503-5.
23. Zhuang Z, Emmert-Buck MR, Roth MJ, Gnarra J, Linehan WM, Liotta LA, Lubensky LA. Von Hippel-Lindau disease gene deletion detected in micro-dissected sporadic human colon carcinoma specimens. Hum Pathol 1996; 27: 152-6.
24. Ginarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen E, Duh FM, et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 1994; 7: 85-90.
25. Herman JG, Latif F, Weng Y, Leman MI, Zbar B, Liu S, Samid D, Duan D-S R, Gnarra JR, Lineban WM, Baylin SB. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-4.
26. Brauch H, Weirich G, Brieger J, Glavac' D, Rodl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Storkel S, Rotter M, Masera A, Gugeler N, Decker H-J. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation. Cancer Res 2000; 60: 1942-8.
27. Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D, Harris AL. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 2002; 62: 2957-61.
28. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Juurgensen JS, Gruber G, Maxwell PH, Loning SA, Frei U, Maher ER, Grone H-J, Eckardt K-U. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res 2001; 61: 5215-22.
29. Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 1999; 19: 1486-97.